India.com News Desk | January 5, 2021 1:33 PM IST
Clarifying his previous statements, Adar Poonawalla tweeted saying exports of vaccines are
SII CEO Adar Poonawalla Says Exports of Vaccines Permitted to All Countries, Issues Clarification
indiacom
2021-01-05T02:33:53+00:00
2021-01-05T02:33:53+00:00
Astrazeneca
India.com Lifestyle Staff | January 5, 2021 10:49 AM IST
Experts reveal some interesting facts that can further strengthen the morale of governments and
Sputnik V and AstraZeneca Collaboration Beneficial For India
indiacom
2021-01-04T23:49:47+00:00
2021-01-04T23:49:47+00:00
Astrazeneca
PTI | January 4, 2021 2:15 PM IST
This is a major milestone in the phased vaccination programme being undertaken in the UK as the
UK Begins Rollout of Oxford-AstraZeneca COVID-19 Vaccine, Elderly Dialysis Patient Gets First Shot
indiacom
2021-01-04T03:15:56+00:00
2021-01-04T03:18:48+00:00
Astrazeneca
India.com News Desk | December 30, 2020 8:46 PM IST
Moreover, the SEC will meet again on January 1 to discuss over granting approval to a Covid-19
Emergency Use Approval Not Granted to Oxford-AstraZeneca Vaccine in India; Next Meet on Jan 1
indiacom
2020-12-30T09:46:07+00:00
2020-12-30T09:46:07+00:00
Astrazeneca
India.com News Desk | December 30, 2020 1:08 PM IST
The Oxford vaccine is economical as compared to other vaccines and it can be stored, transported,
COVID-19: UK Approves Oxford-AstraZeneca Coronavirus Vaccine, A Ray Of Hope For India
indiacom
2020-12-30T02:08:43+00:00
2020-12-30T02:09:56+00:00
Astrazeneca
India.com News Desk | December 11, 2020 6:55 PM IST
The move comes after Russian scientists suggested that combining the two could sharply boost
AstraZeneca to Test Combining Coronavirus Vaccine With Russia's Sputnik V Shot
indiacom
2020-12-11T07:55:03+00:00
2020-12-11T07:55:03+00:00
Astrazeneca
India.com News Desk | December 8, 2020 11:09 PM IST
The university said the new study published in the 'Lancet' medical journal is the first
Oxford-AstraZeneca First To Publish Coronavirus Vaccine Final Trial Results, Efficacy 70 Per cent
indiacom
2020-12-08T12:09:30+00:00
2020-12-08T13:21:31+00:00
Astrazeneca
India.com News Desk | December 7, 2020 7:27 AM IST
Coronavirus Vaccine Update: Citing reasons, the SII said the vaccine was necessary for "unmet
Serum Institute Seeks Emergency Use Authorisation of Oxford Vaccine in India
indiacom
2020-12-06T20:27:40+00:00
2020-12-06T20:27:40+00:00
Astrazeneca
India.com News Desk | December 3, 2020 7:34 AM IST
Last week, the 40-year-old man who was a volunteer in the third phase of the vaccine trial in
No Link Between 'Serious Adverse Event' Suffered by Chennai Participant & Oxford COVID Vaccine Shot, Says DCG
indiacom
2020-12-02T20:34:52+00:00
2020-12-02T20:34:52+00:00
Astrazeneca
India.com News Desk | December 3, 2020 7:12 AM IST
AstraZeneca had briefly paused its study in the vaccine trials in th US in October after a report
Oxford-AstraZeneca Coronavirus Vaccine Results Likely in Late-January: Report
indiacom
2020-12-02T20:12:37+00:00
2020-12-02T20:12:37+00:00
Astrazeneca
India.com News Desk | December 2, 2020 8:22 AM IST
A Chennai-based volunteer had sought to halt vaccine development after he allegedly suffered
Coronavirus Vaccine 'Covishield' Safe, Mishap Won't Affect Rollout Plan, Says Government
indiacom
2020-12-01T21:22:00+00:00
2020-12-01T21:22:00+00:00
Astrazeneca
India.com News Desk | November 29, 2020 9:45 PM IST
A Chennai-based volunteer had sought to halt vaccine development after he allegedly suffered
Serum Institute to Seek 100 cr in Damages From Volunteer Who Said 'Covishield' Vaccine Left Him Unwell
indiacom
2020-11-29T10:45:26+00:00
2020-11-29T10:50:30+00:00
Astrazeneca
India.com News Desk | November 28, 2020 9:05 PM IST
Poonawalla said that SII is in the process of submitting the data for the clinical trials to the
Oxford COVID-19 Vaccine: SII to Seek Emergency Authorisation in Two Weeks, Says CEO Poonawalla
indiacom
2020-11-28T10:05:47+00:00
2020-11-28T20:00:40+00:00
Astrazeneca
India.com News Desk | November 26, 2020 9:38 PM IST
Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford
AstraZeneca-Oxford COVID-19 Vaccine Under Scanner After Error, Serum Institute Says Indian Trials Going Smoot
indiacom
2020-11-26T10:38:24+00:00
2020-11-26T10:39:49+00:00
Astrazeneca
India.com Lifestyle Staff | November 25, 2020 11:44 AM IST
Currently, there are 321 vaccine projects ongoing around the world. Out of which, 40 are tested on
COVID-19 Vaccine Maybe Here by April 2020 But Some Things Are Never Going to be 'Normal' Again
indiacom
2020-11-25T00:44:58+00:00
2020-11-26T05:40:26+00:00
Astrazeneca
India.com News Desk | November 26, 2020 2:13 PM IST
Covishield is currently in the final stage of clinical human trials and has shown 70 per cent
PM Modi to Visit Pune's Serum Institute on November 28 to Review COVID-19 Vaccine Development
indiacom
2020-11-26T03:13:03+00:00
2020-11-26T03:15:20+00:00
Astrazeneca
India.com News Desk | November 24, 2020 7:02 AM IST
A single dose of the Oxford vaccine for coronavirus may cost up to Rs 1,000 if purchased from a
India May Get 100 Million Doses of Oxford's Coronavirus Vaccine by January, Says Adar Poonawalla
indiacom
2020-11-23T20:02:31+00:00
2020-11-23T20:02:31+00:00
Astrazeneca
India.com News Desk | November 23, 2020 1:45 PM IST
"AZD1222's simple supply chain and our no-profit pledge and commitment to broad, equitable and
Oxford-Astrazeneca Vaccine 90% Effective in Preventing COVID, Show Results
indiacom
2020-11-23T02:45:34+00:00
2020-11-23T02:45:34+00:00
Astrazeneca
India.com News Desk | November 23, 2020 6:29 AM IST
Dr Harsh Vardhan also reiterated the government's plan was to immunise 200 million to 250 million
COVID-19: Local Vaccine Final Trials Could End Within Two Months, Says Harsh Vardhan
indiacom
2020-11-22T19:29:59+00:00
2020-11-22T19:29:59+00:00
Astrazeneca
India.com News Desk | November 22, 2020 3:53 PM IST
The Oxford vaccine is already in its third and final phase of clinical trials in India, and if all
India May Grant Serum Institute Emergency Use Authorisation For Oxford-AstraZeneca Vaccine
indiacom
2020-11-22T04:53:37+00:00
2020-11-22T04:53:37+00:00
Astrazeneca
